Refractory Diarrhoea in Hyaline Fibromatosis Syndrome: A 5-Month-Old Infant Stabilized Through Precision Gut-Directed Nutritional Therapy
Journal of Pediatric and Neonatal Sciences · 2026
DOI: 10.67238/jpnb.2026.v2.07 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric and Neonatal Sciences, 2026. Verfasst von Chaitra . und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Hyaline Fibromatosis Syndrome (HFS) is an uncommon autosomal recessive disorder characterized by progressive deposition of hyaline material across multiple organ systems. In infants, the presentation may be subtle initially, but progression often leads to significant gastrointestinal complications. This case highlights a 5-month-old infant presenting with severe refractory diarrhoea, profound feeding difficulty, failure to thrive, and E. coli urosepsis. Conventional management failed, prompting the introduction of a structured gut-directed nutritional therapy involving semi-elemental feeds, osmotic load reduction, and carefully titrated fluid-electrolyte management. The infant demonstrated marked improvement, emphasizing the importance of aligning nutritional strategies with the underlying mucosal pathology in HFS.
Zitieren
APA
., C., & Ratnakar, B. (2026). Refractory Diarrhoea in Hyaline Fibromatosis Syndrome: A 5-Month-Old Infant Stabilized Through Precision Gut-Directed Nutritional Therapy. Journal of Pediatric and Neonatal Sciences. https://doi.org/10.67238/jpnb.2026.v2.07
Vancouver
. C, Ratnakar B. Refractory Diarrhoea in Hyaline Fibromatosis Syndrome: A 5-Month-Old Infant Stabilized Through Precision Gut-Directed Nutritional Therapy. Journal of Pediatric and Neonatal Sciences. 2026. doi:10.67238/jpnb.2026.v2.07
BibTeX
@article{2026,
author = {., Chaitra and Ratnakar, Babu},
title = {Refractory Diarrhoea in Hyaline Fibromatosis Syndrome: A 5-Month-Old Infant Stabilized Through Precision Gut-Directed Nutritional Therapy},
journal = {Journal of Pediatric and Neonatal Sciences},
year = {2026},
doi = {10.67238/jpnb.2026.v2.07}
}
EUVIMED